CardioQ vs Thermodilution Measurements of Cardiac Output

NCT01744795 — Not applicable, Completed, 25 participants, Hasse Moller-Sorensen

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Comparison of CardioQ and Pulmonary Artery Thermodilution Derived Cardiac Output Measurements

RegistryNCT01744795
StatusCompleted
PhaseNot applicable
Study typeInterventional; na, single group, masking: double, diagnostic
Enrollment25 (Estimated)
SponsorHasse Moller-Sorensen (Other)
ConditionsComparison of CardioQ and Thermodilution Derived Cardiac Output Measurements
Interventionsinduced changes in hemodynamics (Other)
Datesstart 2012-12-01, primary completion 2013-06-01, completion 2013-06-01, first posted 2012-12-07, last updated 2013-06-19
Locations2 sites in Denmark

Related Papers Related Patents Related Grants Related Experts
All trials for Comparison of CardioQ and Thermodilution Derived Cardiac Output Measurements All trials of induced changes in hemodynamics

-Summary

Minimal invasive monitoring systems of central hemodynamics are gaining increasing popularity. The present study investigates the precision of the esophageal doppler (CardioQ) derived cardiac output and its agreement with pulmonary artery catheter thermodilution (PAC TD) for measuring CO during steady state and with induced hemodynamic changes in patients scheduled for elective cardiac surgery.

Expand all sections  ·  Collapse all

+Detailed description

Twenty-five patients are planned to be enrolled. After induction of anesthesia, insertion of the PAC and the esophageal-doppler probe, the patient are placed in the following successive positions: a) supine, b) head-down tilt, c) head-up tilt, d) supine, e) supine with phenylephrine administration f) pace heart rate 80 bpm, g) pace heart rate 110 bpm, and CO are measured simultaneously using the CardioQ and PAC TD.

+Arms and interventions

ArmTypeInterventionsDescription
induced changes in hemodynamicsExperimentalOther: induced changes in hemodynamicsTwenty-five patients are planned enrolled. After induction of anesthesia, insertion of the PAC and the CardioQ probe, the patient are placed in the following successive positions: a) supine, b) head-down tilt, c) head-up tilt, d) supine, e) supine with phenylephrine administration f) pace heart rate 80 bpm, g) pace heart rate 110 bpm. CO are measured simultaneously using the CardioQ and thermodilution technique.
  • induced changes in hemodynamics (Other): Twenty-five patients are planned enrolled. After induction of anesthesia, insertion of the PAC and the CardioQ probe, the patient are placed in the following successive positions: a) supine, b) head-down tilt, c) head-up tilt, d) supine, e) supine with phenylephrine administration f) pace heart rate 80 bpm, g) pace heart rate 110 bpm. CO are measured simultaneously using the TEE and thermodilution technique.

+Outcome measures

Primary outcomes

  • Agreement of cardiac output determined with CardioQ, compared with thermodilution [Data are collected in the perioperative period (30min.)]: Data are collected for each patient in the perioperative period. Patients are followed in the first 24 hours. Data will after inclusion of the last data be analysed and appropiate statistics aplied.

+Eligibility

Sex: All, ages: 18 Years to 90 Years

Inclusion Criteria:

* patients scheduled for elective coronary artery bypass grafting (CABG), who are in stable sinus rhythm, who have a left ventricular ejection fraction > 0.40 measured by transthoracic echocardiography, and who have no significant valve pathology

Exclusion Criteria:

\-

+Locations (2)

FacilityCityCountryStatus
Rigshospitalet, University of CopenhagenCopenhagen, Capital RegionDenmark
Department of Cardiothoracic anesthesiology; RigshospitaletCopenhagenDenmark